home / stock / dtcff / dtcff news

DTCFF News and Press, Defence Therapeutics Inc Cl A From 11/30/21

Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
DTCFF DTCFF Quote DTCFF Short DTCFF News DTCFF Articles DTCFF Message Board
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
DTCFF - Defence Therapeutics Vaccines and Program Development

Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), is a publicly-traded biotechnology company working on engineering the next generation vaccines, Antibody Drug Conjugates, ADC ...
DTCFF - Defence Therapeutics Cancer Vaccine AccuVac-D001 Manufacturing Targets Melanoma and Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the establishmen...

DTCFF - Defence Therapeutics Appoints Dr. Riam Shammaa to Its Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - November 9, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on the development of next generation cancer therapeutics and infectious disease vaccines is pl...

DTCFF - Defence Therapeutics Reports Successful Completion of Its COVID-19 Vaccine AccuVAC-PT001 Toxicology Studies in Rabbits

Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a biotechnology company working on the development of next generation cancer therapeutics and infectious disease vaccines is pl...
DTCFF - Defence Therapeutics Accum(TM) Variants in Vitro Study Increases the Potency of T-Deruxtecan ADC by 5-Fold on Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - October 13, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce strong in vitro ...

DTCFF - Defence Therapeutics Prepares for Phase I Trial to Test Its DC Cancer Vaccine, AccuVAC-D002, Against Melanoma

Vancouver, British Columbia--(Newsfile Corp. - October 6, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines, is finalizing all required steps in pr...

DTCFF - Defence Therapeutics to Finalize Its Objectives to Initiate a Phase I Trial Against Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology Company working on cancer therapeutics and infectious diseases vaccines, is pleased to announce that it will ...
DTCFF - Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals

Vancouver, British Columbia--(Newsfile Corp. - September 20, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the development...

DTCFF - Defence Therapeutics Success in Testing Its COVID-19 AccuVAC-PT001 Vaccine in a Non-Rodent Model

Vancouver, British Columbia--(Newsfile Corp. - September 14, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on cancer therapeutics and infectious disease vaccines, is pleased to announce the completion...

DTCFF - Defence Therapeutics Development Program to Engineer a New HPV Vaccine Initiated

Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on ADC therapeutics for cancer targeting with its Accum TM technology and cancer vaccine ther...
Previous 10 Next 10